Table 3.
Descriptive statistics for outcomes and predictors (N=814)
| Clinical baselines | Count | Mean | SD | Min | Max |
|---|---|---|---|---|---|
| Pain baseline (VAS) | 814 | 4.40 | 2.18 | 0 | 10 |
| Function baseline (PSFS) | 814 | 5.15 | 2.97 | 0 | 10 |
| Clinical outcomes | |||||
| Pain outcome (VAS) | 814 | 1.71 | 1.85 | 0 | 10 |
| Function outcome (PSFS) | 814 | 7.82 | 2.36 | 0 | 10 |
| Chronicity | |||||
| Chronic (>3 mo) | 497 | 0.61 | 0.49 | 0 | 1 |
| Subacute (1-3 mo) | 128 | 0.16 | 0.36 | 0 | 1 |
| Acute (<1 mo) | 189 | 0.23 | 0.42 | 0 | 1 |
| Baseline pain level categories | |||||
| Little to no pain (VAS≤1) | 61 | 0.07 | 0.26 | 0 | 1 |
| Mild pain (3.4≤VAS>1) | 218 | 0.27 | 0.44 | 0 | 1 |
| Moderate (7.4≤VAS>3.4) | 475 | 0.58 | 0.49 | 0 | 1 |
| Severe pain (VAS>7.4) | 60 | 0.07 | 0.26 | 0 | 1 |
| Comorbid conditions and adverse symptoms | |||||
| No. of comorbid conditions | 814 | 0.58 | 0.72 | 0 | 5 |
| Reported comorbid conditions | 383 | 0.47 | 0.50 | 0 | 1 |
| No. of adverse symptoms | 814 | 0.51 | 0.89 | 0 | 10 |
| Reported adverse symptoms | 281 | 0.35 | 0.48 | 0 | 1 |